This inventor holds 1 USPTO granted patent. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Alexander Vaynshtein in Cardiac Ablation Technology
Introduction
Alexander Vaynshtein is a notable inventor based in Yokneam, Israel. He has made significant contributions to the field of cardiac technology, particularly in the development of devices aimed at improving heart health. His innovative work has led to the creation of a patent that addresses critical issues in cardiac procedures.
Latest Patents
Vaynshtein holds a patent for "Systems and methods for performing ablation with a left atrial appendage implant device." This patent describes a left atrial appendage (LAA) occlusion or elimination implant device that is further configured to ablate tissue located at an atrium of the heart or nearby veins and ostia. The device can be delivered to a patient's heart using a catheter system and includes a contact member comprising one or more electrodes. In use, the electrodes can perform unipolar or bipolar ablation at an ablation site distinct from the ostium or interior of the LAA. The implant device can then be repositioned at least partially within the LAA, and the contact member can be implanted to occlude or eliminate the LAA. Additionally, the device can include a securing element with electrodes, which cooperate with the contact member in performing ablation and/or occluding or eliminating the LAA. Vaynshtein's innovative approach has the potential to enhance the safety and effectiveness of cardiac procedures.
Career Highlights
Vaynshtein is currently associated with Biosense Webster (Israel) Ltd., a company known for its advancements in electrophysiology and cardiac mapping technologies. His work at this organization has allowed him to collaborate with leading experts in the field and contribute to groundbreaking innovations.
Collaborations
Some of Vaynshtein's notable coworkers include Tomer Zaidenberg and Eli Vaknin. Their collective expertise and collaboration have played a crucial role in advancing the technologies developed at Biosense Webster.
Conclusion
Alexander Vaynshtein's contributions to cardiac technology, particularly through his patent on LAA implant devices, showcase his commitment to improving patient outcomes in heart health. His work continues to influence the field and inspire future innovations.